InterventionsIn silico
Once-Weekly Semaglutide vs. Placebo for the Treatment of Type 2 Diabetes and Chronic Kidney Disease in Denmark—A Long-Term Cost-Effectiveness Analysis Based on Flow
ADA Scientific Sessions 2025 Abstract
The paper
ROSSING P, LINDHARDT M, TIKKANEN CK et al.
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Poster 782-P
